‹ Back to document
Comment from Biotechnology Innovation Organization (BIO)
Anonymous
Analysis pending
See attached file(s)
Attachments
BIO Comment Letter - FDA-2017-D-6530 - Formal Meetings PDUFA doc (PDF)
BIO Comment Letter - FDA-2017-D-6530 - Formal Meetings PDUFA doc (DOCX)
BIO Comment Letter - FDA-2017-D-6530 - Formal Meetings PDUFA pdf (PDF)
View on Regulations.gov →